Association of adverse pregnancy outcomes with glyburide vs insulin inwomen with gestational diabetes

JAMA Pediatrics

Volumn 169, Issue 5, 2015, Pages 452-458

  Castillo, Wendy Camelo ^a,b   Boggess, Kim ^c   Stürmer, Til ^b   Brookhart, M Alan ^b   Benjamin, Daniel K ^d   Funk, Michele Jonsson ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; INSULIN; ANTIDIABETIC AGENT;

ADULT; ARTICLE; ATTRIBUTABLE RISK; BIRTH INJURY; CESAREAN SECTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DELIVERY; DRUG THERAPY; FEMALE; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; JAUNDICE; LARGE FOR GESTATIONAL AGE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS; TREATMENT DURATION; CHEMICALLY INDUCED; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETES, GESTATIONAL; LABOR COMPLICATION; NEWBORN DISEASE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

ADULT; COHORT STUDIES; DIABETES, GESTATIONAL; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INSULIN; OBSTETRIC LABOR COMPLICATIONS; PREGNANCY; PREGNANCY OUTCOME; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 84930693916     PISSN: 21686203     EISSN: 21686211     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2015.74     Document Type: Article

References (26)

1. Getahun D, Nath C, Ananth CV, Chavez MR, Smulian JC. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol. 2008;198(5):525; e1-e5.
2. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS; Kaiser Permanente of Colorado GDM Screening Program. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care. 2005;28(3):579-584.
3. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; Australian Carbohydrate Intolerance Study in PregnantWomen (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477-2486.
4. Holt RI, Lambert KD. The use of oral hypoglycaemic agents in pregnancy. Diabet Med. 2014;31(3):282-291.
5. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2004;27(1) (suppl 1):S88-S90.
6. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134-1138.
7. Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol. 2005;193(1):118-124.
8. Bertini AM, Silva JC, Taborda W, et al. Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med. 2005;33(6):519-523.
9. Camelo Castillo W, Boggess K, Stürmer T, Brookhart MA, Benjamin DK Jr, Jonsson Funk M. Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. Obstet Gynecol. 2014;123(6):1177-1184.
10. Hansen LG, Chang S. Health Research Data for the Real World: The MarketScan Databases. Ann Arbor, MI: Truven Health Analytics; 2009.
11. Agency for Healthcare Research and Quality. Patient Safety Indicators Technical Specifications: Obstetric Trauma Rate: Vaginal DeliveryWith Instrument. Rockville, MD: Agency for Healthcare Research & Quality; 2009.
12. Black MH, Sacks DA, Xiang AH, Lawrence JM. Clinical outcomes of pregnancies complicated by mild gestational diabetes mellitus differ by combinations of abnormal oral glucose tolerance test values. Diabetes Care. 2010;33(12):2524-2530.
13. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316.
14. Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hernández-Díaz S. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf. 2013;22(1):16-24.
15. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550-560.
16. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39(1):33-38.
17. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083-3107.
18. Cheng YW, Chung JH, Block-Kurbisch I, Inturrisi M, Caughey AB. Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes. J Matern Fetal Neonatal Med. 2012;25(4):379-384.
19. Ogunyemi D, Jesse M, Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract. 2007;13(4):427-428.
20. Ramos GA, Jacobson GF, Kirby RS, Ching JY, Field DR. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. J Perinatol. 2007;27(5):262-267.
21. Andrade SE, Moore Simas TA, Boudreau D, et al. Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy. Pharmacoepidemiol Drug Saf. 2011;20(11):1168-1176.
22. Blomberg M. Maternal obesity, mode of delivery, and neonatal outcome. Obstet Gynecol. 2013;122(1):50-55.
23. Catalano PM, McIntyre HD, Cruickshank JK, et al; HAPO Study Cooperative Research Group. The Hyperglycemia and Adverse Pregnancy Outcome Study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35(4):780-786.
24. Stuebe AM, Landon MB, Lai Y, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal BMI, glucose tolerance, and adverse pregnancy outcomes. Am J Obstet Gynecol. 2012;207(1):62; e1-e7.
25. Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care. 2008;31(2):340-346.
26. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009;58(2):453-459.